Evidence map›Paper›PMID 32001795›Full record

ArticleInternational journal of obesity (2005)2020

TL1A regulates adipose-resident innate lymphoid immune responses and enables diet-induced obesity in mice.

Peter Tougaard, Louise Otterstrøm Martinsen, Ditte Olsen Lützhøft, Henrik Elvang Jensen, Mette Flethøj, Peter Vandenabeele, Anders Elm Pedersen, Søren Skov, Axel Kornerup Hansen, Camilla Hartmann Friis Hansen

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of obesity (2005), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Peter TougaardDepartment of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, København, Denmark. peter.tougaard@irc.vib-ugent.be.
Louise Otterstrøm MartinsenDepartment of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, København, Denmark.
Ditte Olsen LützhøftDepartment of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, København, Denmark.
Henrik Elvang JensenDepartment of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, København, Denmark.
Mette FlethøjDepartment of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, København, Denmark.
Peter VandenabeeleMolecular Signaling and Cell Death Unit, VIB-Ugent Center for Inflammation Research, Flanders Institute for Biotechnology, Ghent, Belgium.
Anders Elm PedersenDepartment of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, København, Denmark.
Søren SkovDepartment of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, København, Denmark.
Axel Kornerup HansenDepartment of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, København, Denmark.ORCID http://orcid.org/0000-0003-1575-2507
Camilla Hartmann Friis HansenDepartment of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, København, Denmark.
University of Copenhagen · DKVlaams Instituut voor Biotechnologie · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesTL1A is a pro-inflammatory cytokine that is homologous to TNFα and connected with the development of several chronic inflammatory disorders. The preliminary results of this study indicated reduced fat accumulation in 9-month-old TL1A-deficient mice at steady state. Thus, the objective was to investigate whether TL1A-deficient mice are resistant to the development of high-fat (HF) diet-induced obesity and to investigate the impact on lymphocyte infiltration in adipose tissue.

methodsTL1A-deficient and TL1A-sufficient male BALB/cJ littermate mice were fed a 60% HF diet or a 10% low-fat control diet for 22 weeks. Mouse body composition and weight were monitored, and tissues were processed and evaluated by flow cytometry, qPCR, and histology.

resultsIn this study, the TL1A-deficient HF-diet-fed mice had reduced whole-body weight gain, which was directly explained by a corresponding fat mass reduction (average 37.2%), compared with that of their TL1A-sufficient littermates. Despite previous data showing marked changes in the gut microbial community, TL1A-deficient GF mice also displayed reduced adiposity. Furthermore, the TL1A-deficient mice were resistant to hepatic steatosis and were shown to have improved glucose tolerance, as determined by oral glucose tolerance test (OGTT), and greater insulin sensitivity. In the epididymal white adipose tissue (eWAT), TL1A deficiency in HF-diet-fed mice resulted in a reduced abundance of IL-18Ra

conclusionsThese findings indicate that TL1A plays an important role in regulating adipose tissue mass and that this role is independent of the gut microbiota. Furthermore, we show that TL1A regulates adipose-resident innate lymphocytes and mitochondria-mediated oxidative stress in eWAT.

Indexed as

Tumor Necrosis Factor Ligand Superfamily Member 15Adipose Tissue, WhiteAnimalsBody CompositionBody WeightDiet, High-FatEpididymisImmunity, InnateLymphocytesMaleMiceMice, Inbred BALB CObesityTnfsf15 protein, mouseTumor Necrosis Factor Ligand Superfamily Member 15

Identifiers

PMID32001795
OpenAlexW3004075235

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.